Overall Assessment
Limited Methodological Quality
Assessment created by PaperScorers Medical AI v0.1.0 on Dec 14, 2025
Key Takeaways
- •Rapid PRISMA-guided review included 50 articles (Dec 2022–Feb 2023).
- •Performance varied: strong in economics, weak in maths/med ed.
- •Educational uses: teacher assist and student tutoring; integrity risks persist.
- •Major issues: hallucinations, outdated knowledge, plagiarism circumvention.
- •Calls for assessment redesign, AI-detection use, and policy/training.
Conclusion
Useful early synthesis with clear methods but limited by lack of preregistration, no quality appraisal, and short window; findings are informative but not definitive.
Quick Actions
Quality Dimensions
Integrity & Transparency
Premise
Literature Positioning
Study Provenance
Methodological Assessment
Abstract
Quick Actions
Study Overview
Publication Details
External Resources
Disclaimer: This assessment is generated by AI and should not be the sole basis for clinical or research decisions. Always review the original paper and consult with domain experts.
Suggested Papers
From Our Blog
Publication Bias: The Science We Never See
Journals love 'breakthroughs' and hate 'failures'. Why the 'File Drawer Problem' means half of science is missing.
Randomized Controlled Trials: The Gold Standard
Why is the RCT the king of evidence? Because it is the only way to kill the confounders.
Number Needed to Treat (NNT): The Most Useful Statistic
How many people have to take a drug for one person to benefit? The answer will shock you (and save you money).